Clinical Trial Update: Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study comparing amcenestrant to physician's choice in locally advanced or metastatic estrogen receptor-positive breast cancer. The trial was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Amcenestrant (SAR439859)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2023-03-30